Clinical and Translational Medicine (Jan 2022)
A novel mode of action for COX‐2 inhibition: Targeting ATPase domain of HSP90 induces ubiquitin degradation of new client protein COX‐2
Abstract
No abstracts available.
Clinical and Translational Medicine (Jan 2022)